(Q46150867)

English

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.

scientific article published on 22 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

obsessive-compulsive disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Carlos Alberto de Bragança Pereira

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

J B Diniz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R G Shavitt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A G Hounie

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

I Pimentel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

L M Koran

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S M Dainesi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

E C Miguel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

22 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

297-307

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19164490%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

The psychological treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Quetiapine Addition in Obsessive-Compulsive Disorder: Is Treatment Outcome Affected by Type and Dose of Serotonin Reuptake Inhibitors?

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Are placebo-controlled trials still important for obsessive compulsive disorder?

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: a double-blind cross-over study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Adverse effects of atypical antipsychotics : differential risk and clinical implications

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Issues in the pharmacological treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Citalopram for treatment-resistant obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Creating more effective antidepressants: clues from the clinic

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099423

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46150867&oldid=1568323840"